Sotera Health Company (MUN:SH5)
Germany · Delayed Price · Currency is EUR | Market Cap | 3.77B +33.9% |
| Revenue (ttm) | 1.03B +7.4% |
| Net Income | 102.16M +374.7% |
| EPS | 0.35 +366.8% |
| Shares Out | n/a |
| PE Ratio | 36.90 |
| Forward PE | 15.36 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | n/a |
| Average Volume | n/a |
| Open | 13.20 |
| Previous Close | 13.30 |
| Day's Range | 13.20 - 13.20 |
| 52-Week Range | 9.30 - 16.70 |
| Beta | n/a |
| RSI | 53.04 |
| Earnings Date | May 5, 2026 |
About Sotera Health Company
Sotera Health Company provides sterilization solutions, lab testing, and advisory services for the healthcare industry in the United States, Canada, Europe, and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. The Sterigenics segment offers outsourced terminal sterilization and irradiation services using gamma irradiation, ethylene oxide processing, and electron beam irradiation technologies for medical devices, pharmaceutical, and food safety and advanced applications markets. The Nordion seg... [Read more]
Financial Performance
In 2025, Sotera Health Company's revenue was $1.16 billion, an increase of 5.74% compared to the previous year's $1.10 billion. Earnings were $77.95 million, an increase of 75.79%.
Financial numbers in USD Financial StatementsNews
Sotera Health announces offering of 31.84M shares of common stock for holders
Sotera Health (SHC) Company announced the launch of a secondary offering of 31.84M shares of its common stock. All 31.84M shares are being offered for sale by certain affiliates of…
Sotera Health Announces Secondary Offering of Common Stock
CLEVELAND, May 11, 2026 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC) (the “Company”) today announced the launch of a secondary offering (the “Offering”) of 31,838,253 shares of its common s...
Sotera Health price target lowered to $22 from $24 at Piper Sandler
Piper Sandler analyst Jason Bednar lowered the firm’s price target on Sotera Health (SHC) to $22 from $24 and keeps an Overweight rating on the shares. The firm notes the…
Sotera Health names Alton Shader as CEO
Sotera Health (SHC) announced the appointment of Alton Shader to the role of CEO of the company, effective May 26, as part of a planned leadership transition. Shader will succeed…
Sotera Health Company Earnings Call Transcript: Q1 2026
Q1 2026 saw 10% revenue growth and 10.5% Adjusted EBITDA growth, with margin expansion and strong segment performance, especially in Nordion. The 2026 outlook was reaffirmed, a CEO transition was announced, and all Georgia bellwether legal cases were dismissed.
Sotera Health Delivers Strong First-Quarter 2026 Results and Reaffirms 2026 Outlook
Q1 2026 net revenues increased 10.0%, or 6.5% on a co nstant currenc y basis, compared to Q1 2025 Q1 2026 net income of $27 million or $0.09 per diluted share, compared to a net loss of $13 million or...
Sotera Health Announces Leadership Transition
Alton Shader, CEO of Viant Medical®, to become CEO and join the Board of Directors, effective May 26, 2026 Chairman and CEO Michael B. Petras, Jr. will serve as Executive Chairman of the Board of Dire...
Sotera Health Announces First-Quarter 2026 Earnings Release Date
CLEVELAND, April 21, 2026 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions, lab testing and advisory services f...
Sotera Health price target lowered to $18 from $20 at Barclays
Barclays lowered the firm’s price target on Sotera Health (SHC) to $18 from $20 and keeps an Overweight rating on the shares. The firm adjusted targets in the life science…
Sotera Health Company Transcript: 2026 KeyBanc Capital Markets Healthcare Forum
The forum highlighted strong 2025 results, with 5.2% organic revenue growth and margin expansion. 2026 guidance projects continued growth, supported by capacity investments and disciplined capital allocation. Regulatory changes and segment strategies were discussed, with a focus on long-term value creation.
Sotera Health appoints Kenneth Krause to board of directors
Sotera Health Company (SHC) has appointed Kenneth D. Krause as a new independent director to its Board of Directors. Mr. Krause has served as Executive Vice President and CFO of…
Sotera Health Appoints Kenneth D. Krause to the Board of Directors
CLEVELAND, March 16, 2026 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC) (the “Company” or “Sotera Health”), a leading global provider of mission-critical end-to-end sterilization solutions, ...
Sotera Health Company Transcript: Barclays 28th Annual Global Healthcare Conference
Energy and supply chain risks are well managed with fixed contracts and no current constraints. Strong financial performance in 2025 is expected to continue in 2026, with robust demand for ethylene oxide sterilization and stable pricing. Regulatory and litigation challenges are being addressed proactively.
Sotera Health offers to sell 25M shares of common stock for holders
Sotera Health (SHC) announced the launch of a secondary offering of 25 million shares of its common stock, par value $0.01 per share. All 25 million shares are being offered…
Sotera Health price target raised to $23 from $21 at Citi
Citi analyst Patrick Donnelly raised the firm’s price target on Sotera Health (SHC) to $23 from $21 and keeps a Buy rating on the shares.
Sotera Health price target raised to $23 from $21 at Citi
Citi raised the firm’s price target on Sotera Health (SHC) to $23 from $21 and keeps a Buy rating on the shares. The company established FY26 guidance calling for total…
Sotera Health Company Earnings Call Transcript: Q4 2025
Delivered 20th consecutive year of revenue growth in 2025, with strong margin expansion and cash flow. 2026 guidance calls for 5–6.5% revenue growth and further EBITDA improvement, supported by robust med tech demand and disciplined capital allocation.
Sotera Health General Counsel Alex Dimitrief to transition to outside advisor
Effective April 1, 2026, Alex Dimitrief, Senior Vice President and General Counsel, will transition to an outside advisor to the Company. Erika Ostrowski, who has served as Sotera Health’s (SHC)…
Sotera Health Delivers 20th Consecutive Year of Revenue Growth and Provides 2026 Outlook
2025 net revenues increased 5.7% to $1.164 billion , compared to 2024, or 5.2% on a constant currency basis 2025 net income increased to $78 million or $0.27 per diluted share, compared to net income ...
Sotera Health Announces Fourth-Quarter and Full-Year 2025 Earnings Release Date
CLEVELAND, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions, lab testing and advisory services fo...
Sotera Health appoints Kyle to board of directors
Sotera Health (SHC) announced it has appointed Richard Kyle as a new independent director to its Board of Directors. Kyle will serve as a member of the Leadership Development and…
Sotera Health Appoints Richard Kyle to the Board of Directors
CLEVELAND, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions, lab testing and advisory services fo...
Sotera Health Company Transcript: 44th Annual J.P. Morgan Healthcare Conference
The company reported strong 2025 results, surpassing $1.16 billion in revenue and exceeding growth and margin targets. Strategic investments in capacity, regulatory readiness, and integrated services position it for continued growth, with robust demand across all business segments and favorable legal outcomes supporting long-term confidence.
Sotera Health sees FY25 revenue over $1.16B, consensus $1.16B
Sotera Health (SHC) Company is presenting at the 44th Annual J.P. Morgan Healthcare Conference. During the presentation, Management will be providing an update on Sotera Health’s business. “Sotera Hea...
Sotera Health to Showcase Continued Revenue Growth and Strategic Value Creation at 44th Annual J.P. Morgan Healthcare Conference
CLEVELAND, Jan. 12, 2026 (GLOBE NEWSWIRE) -- Sotera Health Company (“Sotera Health” or the “Company”) (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions, l...